Scientists around the world are resuming trials of the controversial drug hydroxychloroquine for possible use against COVID-19, after the retraction of a heavily criticised study into its effects and side-effects. Now the paper has been retracted, and the WHO trials are back on after several of the paper's authors said they were not able to verify the contents of a database at the heart of the study.

Lancet cities lack of data authenticity: Study that paused HCQ trails now retracted

who-trials-on-hcq

Who Trials On Hcq, News on Who Trials On Hcq, stories on Who Trials On Hcq, articles on Who Trials On Hcq, Who Trials On Hcq stories at Wion, Who Trials On Hcq news, Who Trials On Hcq latest news

who trials-on-hcq

Lancet cities lack of data authenticity: Study that paused HCQ trails now retracted